BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25742894)

  • 1. Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.
    Miura S; Kagamu H; Sakai T; Nozaki K; Asakawa K; Moro H; Okajima M; Watanabe S; Yamamoto S; Iino N; Goto S; Kazama JJ; Yoshizawa H; Narita I
    Intern Med; 2015; 54(1):55-8. PubMed ID: 25742894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.
    Lemma GL; Lee JW; Aisner SC; Langer CJ; Tester WJ; Johnson DH; Loehrer PJ
    J Clin Oncol; 2011 May; 29(15):2060-5. PubMed ID: 21502559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma.
    Igawa S; Murakami H; Takahashi T; Nakamura Y; Tsuya A; Naito T; Kaira K; Ono A; Shukuya T; Tamiya A; Endo M; Yamamoto N
    Lung Cancer; 2010 Feb; 67(2):194-7. PubMed ID: 19409644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of thymic cancer effectively treated by weekly paclitaxel combined with carboplatin].
    Kondo R; Watanabe S; Ishikawa D; Tanaka T; Ohshima Y; Asakawa K; Sakagami T; Okajima M; Miura S; Hayashi Y; Tanaka J; Kagamu H; Yoshizawa H; Narita I
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2607-9. PubMed ID: 25596057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L.
    Hirai F; Yamanaka T; Taguchi K; Daga H; Ono A; Tanaka K; Kogure Y; Shimizu J; Kimura T; Fukuoka J; Iwamoto Y; Sasaki H; Takeda K; Seto T; Ichinose Y; Nakagawa K; Nakanishi Y;
    Ann Oncol; 2015 Feb; 26(2):363-8. PubMed ID: 25403584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent invasive thymic cancer showing a stable disease to carboplatin plus paclitaxel].
    Igawa S; Yanagisawa N; Makita S; Iida Y; Maki S; Kimura Y; Otani S; Hayashi N; Takakura A; Katono K; Onoda S; Yamamoto M; Masuda N
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2161-3. PubMed ID: 21084818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
    Imbimbo M; Vitali M; Fabbri A; Ottaviano M; Pasello G; Petrini I; Palmieri G; Berardi R; Zucali P; Ganzinelli M; Marabese M; Broggini M; Marino M; Trama A; Rulli E; Hollander L; Pruneri G; Torri V; Garassino MC
    Clin Lung Cancer; 2018 Sep; 19(5):e811-e814. PubMed ID: 30033090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature.
    Watanabe K; Shinkai M; Goto H; Yoshikawa S; Yamaguchi N; Hara Y; Shinoda M; Moriyama Y; Rubin BK; Ishigatsubo Y; Kaneko T
    Tumori; 2013; 99(4):e172-6. PubMed ID: 24326856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage chemotherapy with carboplatin and paclitaxel for cisplatin-resistant thymic carcinoma--three cases.
    Komatsu Y; Koizumi T; Tanabe T; Hatayama O; Yasuo M; Okada M; Yamamoto H; Kubo K; Sasabayashi M; Tsunoda T
    Anticancer Res; 2006; 26(6C):4851-5. PubMed ID: 17214351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Advanced Squamous Cell Lung Cancer with Hemodialysis Treated with Carboplatin and Paclitaxel].
    Yajima K; Hasegawa Y; Koga A; Okumura T; Yamashita K; Isogaki J; Suzuki K; Kawabe A
    Gan To Kagaku Ryoho; 2018 Aug; 45(8):1189-1192. PubMed ID: 30158417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer.
    Furugen M; Sekine I; Tsuta K; Horinouchi H; Nokihara H; Yamamoto N; Kubota K; Tamura T
    Jpn J Clin Oncol; 2011 Aug; 41(8):1013-6. PubMed ID: 21742653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel second line chemotherapy treatment of recurrent thymoma.
    Jan N; Villani GM; Trambert J; Fehmian C; Sood B; Wiernik PH
    Med Oncol; 1997; 14(3-4):163-8. PubMed ID: 9468040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
    Fukuda M; Obase Y; Miyashita N; Kobashi Y; Mohri K; Ueno S; Hayama M; Shimizu K; Nishimura H; Nakata M; Oka M
    Anticancer Res; 2007; 27(3B):1601-4. PubMed ID: 17595782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An advanced invasive thymoma that responded remarkably to neoadjuvant chemotherapy with carboplatin, adriamycin, and etoposide].
    Bando S; Ikeda T; Yamanouchi H; Ohnishi T; Yamaji Y; Fujita J; Takahara J; Maeda M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1135-40. PubMed ID: 8544388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors.
    Wang CL; Gao LT; Lyu CX; Zhang Q; Zeng WQ; Fang WT; Zhu L; Fu XL
    Med Oncol; 2022 Jan; 39(2):25. PubMed ID: 34982283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer.
    Watanabe M; Aoki Y; Tomita M; Sato T; Takaki Y; Kato N; Kikuchi M; Kase H; Tanaka K
    Gynecol Oncol; 2002 Feb; 84(2):335-8. PubMed ID: 11812097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive multimodality treatment of invasive thymic carcinoma.
    Greene MA; Malias MA
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):434-6. PubMed ID: 12579125
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complete resection for giant thymic carcinoma after simultaneous combination chemotherapy].
    Ueki T; Ueshima Y; Kurioka H; Enoki Y; Hosokawa Y
    Kyobu Geka; 2005 Apr; 58(4):320-3. PubMed ID: 15828254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with metastatic urothelial carcinoma--a case report].
    Furuya Y; Takihana Y; Araki I; Tanabe N; Takeda M
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):1017-20. PubMed ID: 12894722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of Amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma: North Japan Lung Cancer group study 0803.
    Inoue A; Sugawara S; Harada M; Kobayashi K; Kozuki T; Kuyama S; Maemondo M; Asahina H; Hisamoto A; Nakagawa T; Hotta K; Nukiwa T
    J Thorac Oncol; 2014 Dec; 9(12):1805-9. PubMed ID: 25393793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.